| Date | Title | Description |
| 26.10.2024 | Monopar Therapeutics: A High-Stakes Gamble in Biotech | Monopar Therapeutics is riding a rollercoaster. The company’s stock surged over 400% in a single day, fueled by a licensing deal with AstraZeneca. This spike has drawn attention, but it also raises questions. Is this a genuine opportunity o... |
| 25.10.2024 | Innovations in Drug Delivery: A Leap Towards the Future | In the ever-evolving landscape of healthcare, innovation is the lifeblood that keeps the industry vibrant. Recently, two significant events showcased groundbreaking advancements in drug delivery and biopharmaceuticals. The PDA Universe of P... |
| 25.10.2024 | Monopar Therapeutics Skyrockets 400% on Licensing Deal Monopar Therapeutics (NASDAQ: MNPR) surged over 400% on Thursday after securing a licensing deal with AstraZeneca for a once-terminated Phase 3 d... |
Monopar Therapeutics (NASDAQ: MNPR) saw its stock skyrocket over 400% on Thursday after announcing a licensing deal with AstraZeneca. By 2 PM, the stock had traded over 10 million shares, far above its usual daily volume of 800,000.
This s... |
| 25.10.2024 | Rebrandly launches Strategic Advisory Board, welcomes Michael Kaplan | Rebrandly, the world’s leading branded link management platform, announced the formation of its Strategic Advisory Board. This diverse group of industry leaders and experts will guide the company’s global expansion, product roadmap, and eng... |
| 24.10.2024 | Global Biopharma Thought Leaders Gather in London: Join the 2024 GenScript Biotech Global Forum for Cutting-Edge Insights | PISCATAWAY, N.J., Oct. 24, 2024 /PRNewswire/ -- Cell therapy, gene therapy, and mRNA vaccines are revolutionizing healthcare, offering innovative treatments for a wide range of diseases. However, as these therapies progress, they encounter ... |
| 22.10.2024 | Wainzua: A New Hope for Patients with Hereditary Transthyretin-Mediated Amyloidosis | In the world of medicine, every breakthrough is a beacon of hope. Wainzua, also known as eplontersen, shines brightly as it moves closer to approval in the European Union. This innovative treatment targets hereditary transthyretin-mediated ... |
| 22.10.2024 | PDA Announces 2024 Drug Delivery Innovation Award Winners at Universe of Pre-Filled Syringes Conference | The PDA Drug Delivery Innovation Awards are given out at the UPS Conference each year.
The 2024 Innovation Award is presented to Joel A. Gresham, Lead Engineer, Crux Product Design and Simon J. Dell, Senior Principal Scientist – Device Deve... |
| 21.10.2024 | Wainzua recommended for approval in the EU | Wainzua recommended for approval in the EU
Mon, Oct 21, 2024 08:00 CET Report this content
21 October 2024
Wainzua (eplontersen) recommended for approval in the EU by CHMP for the treatment of adult patients with polyneuropathy associated w... |
| 18.10.2024 | The Microbiome Revolution: Holobiome's $9 Million Leap Forward | In the world of health and wellness, the gut is the new frontier. Holobiome, a microbiome platform company, has just secured $9 million in a Seed funding round. This investment is not just a financial boost; it’s a signal that the microbiom... |
| 18.10.2024 | Positive progress in addressing unmet medical needs |
The FDA has granted Fast Track designation to Neurimmune’s partner Alexion, AstraZeneca Rare Disease Fast Track designation for the development of ALXN2220 (formerly NI006) for the treatment of transthyretin amyloidosis with cardiomyopathy... |
| 18.10.2024 | LaNova Medicines Announces Initiation of Phase 1 Clinical Trial of Anti-PD-1/VEGF Bispecific Antibody LM-299 and Completion of $42 Million Series C1 Financing | Phase 1 trial of LM-299, an anti-PD-1/VEGF BsAb, initiated in China for advanced solid tumors following promising preclinical results demonstrating strong inhibition of tumor growth and well-tolerated safety profile
IND for LM-299 in the US... |
| 18.10.2024 | Consumer groups ask FTC to block Novo Holdings-Catalent deal | Boards, Policy & RegulationMergers & Acquisitions
Regulatory Oversight
Corporate Counsel
Health
Consumer groups ask FTC to block Novo Holdings-Catalent deal
By Jody Godoy and Maggie FickOctober 17, 20249:55 PM UTCUpdated ago
Text
Sm... |
| 15.10.2024 | Holobiome: Microbiome Platform Company Raises $9 Million (Seed) | Holobiome announced it closed an oversubscribed Seed round of $9M. The funding round was led by iSelect Fund, with major participation from Corundum Systems Biology, Satori Neuro, SkyRiver Ventures, Pace Ventures, Valor Equity Partners, and... |
| 14.10.2024 | BioCity will present the late-breaking clinical trial data of its ETA selective antagonist SC0062 at the American Society of Nephrology (ASN) 2024 with simultaneous publication of the trial data in th... | SHANGHAI, Oct. 14, 2024 /PRNewswire/ -- BioCity Biopharma announced that a late-breaking clinical trial abstract of its endothelin receptor type A (ETA) selective antagonist SC0062 has been selected for oral presentation at ASN Kidney Week ... |
| 10.10.2024 | The Healthcare Landscape in 2024: Challenges and Innovations | As we navigate through 2024, the healthcare sector stands at a crossroads. The challenges are formidable, yet the opportunities for innovation are ripe. From staffing shortages to the integration of artificial intelligence, the landscape is... |
| 10.10.2024 | The Double-Edged Sword of AI in Innovation and Security | Artificial Intelligence (AI) is a double-edged sword. On one side, it fuels innovation, sparking creativity and new ideas. On the other, it raises significant security concerns, especially in software development. Recent studies reveal a co... |
| 10.10.2024 | Релиз языка программирования Julia 1.11 | 8 октября 2024 года состоялся релиз языка программирования Julia 1.11. Проект сочетает в себе такие качества как высокая производительность, поддержка динамической типизации и встроенные средства для параллельного программирования.
Синтакси... |
| 10.10.2024 | Kurma Partners: First Closing Of €250 Million Biofund IV | Kurma Partners, an asset manager focused on improving human health, announced that it has raised EUR 140 million, completing the first closing of Biofund IV. By the final closing in 2025, Kurma aims to have raised a total of €250 million in... |
| 08.10.2024 | Storj Acquires PetaGene, Creator of Distributed Mount Client cunoFS, to Enhance Capabilities for AI and Data-Intensive Industries | Today Storj announces the acquisition of PetaGene, creator of cunoFS, to build on growth propelled by Storj’s recent acquisition of distributed GPU provider, Valdi. With today’s news, Storj now delivers distributed cloud object storage, dis... |
| 08.10.2024 | Registrational Phase III Studies of APG-2449 Cleared by China CDE for the Treatment of Patients with NSCLC | ROCKVILLE, Md. and SUZHOU, China, Oct. 8, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily f... |
| 08.10.2024 | 85% of Global Innovators Using GenAI for Research and Learning | New study from Wazoku and King’s Business School reveals extent that AI is supporting and powering innovation and new ideas
Generative AI and Large Language Models (LLMs) are increasingly being used to drive global innovation, according to ... |
| 07.10.2024 | Shaping the Future: The AI Summit New York 2024 | The AI Summit New York, the most important event for commercially-applied AI, returns to the Javits Center December 11 – 12 with a bigger and better show. In its 9th edition, the conference convenes 4,000 forward-thinking technologists and ... |
| 07.10.2024 | AstraZeneca licenses lipid lowering Lp(a) asset | AstraZeneca licenses lipid lowering Lp(a) asset
Mon, Oct 07, 2024 10:30 CET Report this content
7 October 2024
AstraZeneca strengthens its cardiovascular pipeline with agreement for a pre-clinical novel lipid-lowering therapy
AstraZeneca ha... |
| 04.10.2024 | Igniting Futures: The Power of STEM Exploration Day | In a world where technology reigns supreme, the future hinges on innovation. The Children's Museum of Indianapolis recognized this truth by hosting STEM Exploration Day, a vibrant event designed to inspire young girls to embrace careers in ... |
| 04.10.2024 | Qure.ai: $65 Million (Series D) Raised To Expand Into More Markets | Mumbai-based global healthcare AI company Qure.ai announced it raised a $65 million Series D funding round. This funding round will expedite expansion in the US market and other geographies, invest more in foundational AI models, and enable... |
| 04.10.2024 | Navigating 2024 Healthcare Challenges: Policy, AI, and the Road Ahead | Bill Charnetski, EVP of Health System solutions and Government Affairs at PointClickCare
Now that we’re halfway through 2024, we’ve gained significant insights into the most pressing healthcare issues facing our industry and how they might ... |
| 03.10.2024 | Kurma Partners raises €140 million first close of new €250 million Biofund IV | Paris-based Kurma Partners, an asset manager focused on improving human health, announced that it has raised €140 million, successfully completing the first closing of Biofund IV. Kurma aims to have raised a total of €250 million in its new... |
| 03.10.2024 | Strathclyde Uni Launches New Microelectronics Lab | The University of Strathclyde has opened a state-of-the-art engineering laboratory, with hopes that it will allow students to gain practical design, implementation and test experience of techniques required to create combined hardware and s... |
| 02.10.2024 | LetsGetChecked finalizes acquisition of Truepill | Photo: d3sign/Getty Images
At-home diagnostics company LetsGetChecked announced it has finalized its acquisition of digital pharmacy and telehealth startup Truepill.
LetsGetChecked offers at-home tests for sexual health, diabetes, thyroid, ... |
| 02.10.2024 | APAC LIVER DISEASE ALLIANCE HOSTS "HEP-FREE: ELIMINATING ASIA'S SILENT PUBLIC HEALTH THREAT BY 2030" SUMMIT IN BANGKOK ON 1 OCTOBER 2024 | BANGKOK, Oct. 2, 2024 /PRNewswire/ -- The APAC Liver Disease Alliance, in collaboration with Thailand's Department of Disease Control, Ministry of Public Health, kicks off the Alliance's inaugural "Hep-Free: Eliminating Asia's Silent P... |
| 02.10.2024 | Owkin Partners with AstraZeneca for Advanced AI gBRCA Pre-Screening | Share
Tweet
Share
Share
Email
Owkin has partnered with AstraZeneca to develop an AI gBRCA pre-screen solution for breast cancer.
Takeaway Points Owkin has partnered with AstraZeneca to develop an AI gBRCA pre-screen solution for breast canc... |
| 30.09.2024 | 5 Habits, die Gründer:innen ein längeres Leben ermöglichen | Länger leben – ein Wunsch, der besonders in der Startup-Szene zunehmend an Bedeutung gewinnt. Gründer:innen stehen häufig unter Stress, wollen gleichzeitig aber möglichst viel Mehrwert schaffen. Immer mehr Unternehmer:innen sprechen davon, ... |
| 27.09.2024 | Global healthcare AI startup Qure.ai raises $65M in Series D round led by Lightspeed and 360One Asset
Recommended Stories For You | AI-driven healthcare startup Qure.ai has raised $65 million in its Series D funding round. The round was led by Lightspeed and 360 ONE Asset, with participation from Merck Global Health Innovation Fund and Kae Capital. Existing investors su... |
| 27.09.2024 | Lightspeed and 360 ONE Asset Lead USD 65 Mn Series D Funding for Qure.ai's Global Healthcare AI Expansion With the raised funds, Qure.ai aims to expand in the US and global markets, advance AI models,... | AI-driven healthcare startup Qure.ai has raised USD 65 million in its Series D funding round led by Lightspeed and 360 ONE Asset, with participation from other prominent investors such as Merck Global Health Innovation Fund and Kae Capital.... |
| 26.09.2024 | Tagrisso US approval in unresectable lung cancer | Tagrisso US approval in unresectable lung cancer
Thu, Sep 26, 2024 08:00 CET Report this content
26 September 2024
Tagrisso approved in the US for patients with
unresectable, Stage III EGFR-mutated lung cancer
Based on LAURA Phase III trial... |
| 26.09.2024 | Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing | Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com
NEW YORK, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presen... |
| 26.09.2024 | Qure.ai, a Global Healthcare AI Innovator, Raises $65 Million in Series D Funding Led by Lightspeed and 360One Asset | Qure.ai, a global healthcare AI innovator, has announced the completion of a $65 million Series D funding round. The investment will expedite expansion into the US market and other geographies, increase investment into foundational AI model... |
| 26.09.2024 | AstraZeneca in AI collaboration with Immunai to inform cancer drug trials | AstraZeneca will pay $18 million to biotechnology firm Immunai Inc to use the New York-based firm's AI model of the immune system to make certain cancer drug trials more efficient, the latter said on Thursday.
This is the latest in a string... |
| 25.09.2024 | Qure.ai Raises $65M to Expand Healthcare AI Solutions Globally | What You Should Know:
– Qure.ai, a prominent global innovator in healthcare AI, has successfully closed a $65M in Series D funding round led by Lightspeed and 360 ONE Asset, with contributions from Merck Global Health Innovation Fund and Ka... |
| 25.09.2024 | Ученые обнаружили, что заразные формы рака вызваны изменением окружающей среды | У медузоподобных существ, называемых гидрами, при избыточном питании могут развиваться опухоли, которые, в свою очередь, могут передаваться их потомству. Новое исследование, посвященное этому явлению не только раскрыло подробности процесса ... |
| 25.09.2024 | Amcor plc announces changes to Board of Directors | ZURICH, Sept. 25, 2024 /PRNewswire/ -- Amcor plc (NYSE: AMCR; ASX: AMC) today announced that Graham Chipchase has been nominated as a non-executive director for election at the Company's Annual Meeting of Shareholders on Wednesday, November... |
| 25.09.2024 | Synple chem joins US-based eMolecules |
Founded by Benedikt Wanner (Founder & CEO) AND Paula Nichols (Co-founder and CCO) along with their team, Synpl Chem is a pioneering Zurich-based company that specializes in automated chemical synthesis for small molecules drug discover... |
| 24.09.2024 | World Top-Performing Incubator Conference 2024: Integrate Global Resources to Jointly Portray a New Blueprint for Incubation | SHANGHAI, Sept. 24, 2024 /PRNewswire/ -- "Boundless Innovation, Collaborative Synergy" — World Top-Performing Incubator Conference 2024 will be held in Lingang Shanghai from September 26 to 28. In the three-day agenda, the World T... |
| 24.09.2024 | AstraZeneca earns 3 different workplace certifications across its operations in North Africa and Levant in 2024 | DUBAI, UAE – Media OutReach Newswire – 24 September 2024 – AstraZeneca, a global leader in the pharmaceutical and biotechnology sector, has been recognized with three prestigious workplace certifications across its operations in North Afric... |
| 23.09.2024 | FDA одобрило первую вакцину против гриппа в форме назального спрея, в том числе для домашнего использования | Впервые Управление по санитарному надзору за качеством продуктов и медикаментов США (FDA) одобрило вакцину против гриппа в виде назального спрея для самостоятельного использования. С осени следующего года FluMist AstraZeneca, которая в 2003... |
| 23.09.2024 | Fasenra recommended for EU approval in EGPA | Fasenra recommended for EU approval in EGPA
Mon, Sep 23, 2024 08:05 CET Report this content
23 September 2024
Fasenrarecommended for approval in the EU by CHMP for the treatment of
eosinophilic granulomatosis with polyangiitis
New indicatio... |
| 23.09.2024 | Impressive preliminary objective response rates (ORR) of 36% in NSCLC and 80% in EGFRmut NSCLC: Interim Results of a Phase 1 Study of BC3195, a First-in-Class ADC Targeting CDH3, Presented by BioCity ... | SHANGHAI, Sept. 23, 2024 /PRNewswire/ -- On September 14, 2024, BioCity presented interim clinical results on the safety and efficacy of its first-in-class antibody-drug conjugate (ADC) BC3195 targeting CDH3 (P-Cadherin) in a Phase I clinic... |
| 23.09.2024 | Final OS results reported for TROPION-Breast01 | Final OS results reported for TROPION-Breast01
Mon, Sep 23, 2024 08:00 CET Report this content
23 September 2024
Datopotamab deruxtecan final overall survival results reported in
patients with metastatic HR-positive, HER2-low or negative br... |
| 21.09.2024 | FluMist: A Game Changer in Influenza Vaccination | In a world where health is paramount, the recent approval of FluMist for self-administration in the United States marks a significant leap forward. This needle-free nasal spray is now the only influenza vaccine that individuals can administ... |
| 20.09.2024 | FluMist approved for self-administration in US | FluMist approved for self-administration in US
Fri, Sep 20, 2024 19:04 CET Report this content
20 September 2024
FluMist approved for self-administration in the US
Only influenza vaccine approved for self- or caregiver-administration at hom... |
| 19.09.2024 | 2024 ISPE Pharma 4.0™ and Annex 1 Conference Featured Speakers Are Announced | The 2024 ISPE Pharma 4.0™ and Annex 1 Conference will take place on 10-11 December in Rome, Italy, and virtually.
The 2024 ISPE Pharma 4.0™ and Annex 1 Conference will take place on 10-11 December in Rome, Italy, and virtually.
NORTH BETHES... |
| 19.09.2024 | Fortune 500 giant will open bioanalytical laboratory in Gothenburg | Fortune 500 giant will open bioanalytical laboratory in Gothenburg
Thu, Sep 19, 2024 07:45 CET Report this content
Thermo Fisher Scientific will expand its bioanalytical presence in Europe and has chosen Gothenburg, Sweden, as a base for it... |
| 19.09.2024 | Gothenburg to host the Nordics’ largest life science partnering event | Gothenburg to host the Nordics’ largest life science partnering event
Thu, Sep 19, 2024 14:00 CET Report this content
NLSDays, an important partnering and investment conference for the life science sector in the Nordics, will be held in Got... |
| 19.09.2024 | Радиофармацевтические препараты назвали прорывом в борьбе с раком | Производители лекарств делают ставку на то, что доставка радиации непосредственно к опухолям станет следующим большим прорывом в борьбе с раком. Bristol Myers Squibb, AstraZeneca, Eli Lilly и другие фармацевтические компании потратили около... |
| 18.09.2024 | Senhwa Biosciences Announces IND Submission to US FDA for Pilot Study of Pidnarulex Pharmacodynamics in Patients with Advanced Solid Tumors sponsored by NCI | TAIPEI and SAN DIEGO, Sept. 18, 2024 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), , a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced that an I... |
| 18.09.2024 | Oxera Chooses Box for Intelligent Content Management | Box, Inc. (NYSE:BOX), the leading Intelligent Content Cloud, today announced that Oxera Consulting LLP (Oxera) selected Box as its centralized cloud platform to intelligently manage and work with content across the enterprise. A European co... |
| 18.09.2024 | FASENRA EGPA US FDA APPROVAL | FASENRA EGPA US FDA APPROVAL
Wed, Sep 18, 2024 08:45 CET Report this content
18 September 2024
Fasenra approved in the US for eosinophilic granulomatosis with polyangiitis
New indication supported by the MANDARA trial which showed nearly 60... |
| 14.09.2024 | Live from ESMO 2024 | Ascentage Pharma Releases Latest Data Showing Sustained Clinical Efficacy of Olverembatinib in SDH-Deficient GIST during a Mini Oral Presentation | ROCKVILLE, Md. and SUZHOU, China, Sept. 14, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily... |
| 14.09.2024 | SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024 | Research highlights the use of multimodal machine learning to identify non-small cell lung cancer patients predicted to derive the most benefit from combination immunotherapy
BOSTON and ROLLE, Switzerland, Sept. 14, 2024 /PRNewswire/ -- SOP... |
| 12.09.2024 | AstraZeneca's AI Revolution: A New Dawn in Disease Detection and Workplace Culture | In the realm of healthcare, the dawn of artificial intelligence (AI) is akin to the first light breaking through a dense fog. AstraZeneca, a pharmaceutical giant, is at the forefront of this transformation. Their innovative AI tool, MILTON,... |
| 11.09.2024 | Revolutionizing Cancer Diagnostics: The Promise of Liquid Biopsy and ecDNA Detection | In the realm of cancer diagnostics, innovation is the lifeblood. Two recent collaborations highlight a seismic shift in how we approach cancer detection and treatment. SOPHiA GENETICS, a leader in data-driven medicine, is at the forefront o... |
| 11.09.2024 | Pioneering Cancer Treatments Take Center Stage at ESMO 2024 | The European Society of Medical Oncology (ESMO) Congress 2024 is set to be a pivotal event in the world of oncology. From September 13 to 17, Barcelona will host a gathering of minds, all focused on the latest breakthroughs in cancer treatm... |
| 11.09.2024 | Технология искусственного интеллекта может обнаружить ранние признаки более 1000 заболеваний, согласно исследователям... | Компьютерный алгоритм под названием MILTON анализирует результаты анализов пациентов, которые обычно собирают врачи, чтобы выявить закономерности в данных и с высокой степенью вероятности предсказать диагноз.
Фармацевтический гигант AstraZe... |
| 10.09.2024 | Veeva Systems: Pioneering the Future of Clinical Trials and Regulatory Efficiency | In the fast-paced world of biopharmaceuticals, time is money. Every day saved in clinical trials can mean the difference between life-saving drugs reaching patients or languishing in bureaucratic limbo. Veeva Systems, a titan in cloud softw... |
| 10.09.2024 | SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing | The companies commit to bring cutting-edge liquid biopsy testing to 20 institutions globally over the next 12 months
BOSTON and ROLLE, Switzerland, Sept. 10, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare tec... |
| 09.09.2024 | Major Release of Veeva Site Connect Streamlines Clinical Trial Execution for Sites and Sponsors | New capabilities and simple, standard site experience cut trial time and expense
Fixed price implementation to get up and running quickly
Industry advances to connected trials as
seven of the top 20 biopharmas adopt Veeva Site Connect
SEOUL... |
| 09.09.2024 | ESMO 2024 | Ascentage Pharma to Present Updated Data of Olverembatinib in Patients with SDH-Deficient GIST during a Mini Oral Presentation at the 2024 ESMO Congress | ROCKVILLE, Md. and SUZHOU, China, Sept. 9, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for malign... |
| 09.09.2024 | AstraZeneca Recognized as the First Company in Egypt to Achieve the Best Place to Work for Working Parents Certification | CAIRO, EGYPT – Media OutReach Newswire – 9 September 2024 – AstraZeneca Egypt has recently been awarded the prestigious Best Place to Work for Working Parents certification highlighting its unwavering commitment to supporting employees with... |
| 09.09.2024 | Sweden’s second city offers fertile ground for tech companies | Sweden’s second city offers fertile ground for tech companies
Mon, Sep 09, 2024 11:19 CET Report this content
Digitalisation is reshaping the world as we know it. The ICT sector is growing fast, not least in Gothenburg, Sweden, where streng... |
| 05.09.2024 | Carbyon and Tencent: Two Titans Tackle Tomorrow's Challenges | In a world grappling with climate change and digital transformation, two companies stand out: Carbyon and Tencent. Each is forging a path toward a sustainable and technologically advanced future. Their recent developments signal a shift in ... |
| 05.09.2024 | The Race for Innovation: LG Innotek and Tencent Drive Global Tech Leadership | In the fast-paced world of technology, two giants are carving their paths: LG Innotek and Tencent. Both companies are racing to dominate their respective fields, driven by innovation and a hunger for market leadership. LG Innotek is making ... |
| 05.09.2024 | Tencent Unveils New AI Upgrades, Proprietary Innovations, and Global Solutions | New tools aim to empower enterprises to achieve new growth with digital-driven efficiency, capitalize on emerging trends and expand globally
Tencent Cloud reports strong international growth with consistent double-digit growth for three con... |
| 05.09.2024 | Respected pharma data science pioneer Dr Ben Sidders to spearhead Biorelate's next growth phase as Chief Scientific Officer | Ben Sidders
* Dr Sidders brings two decades of deep data science experience, honed across multiple therapeutic areas at Pfizer and AstraZeneca * He will build on Biorelate's strong track record of leveraging advanced data science methods to... |
| 03.09.2024 | SKIES ACROSS NORTH AMERICA TO LIGHT UP THIS FALL IN SUPPORT OF BLOOD CANCER PATIENTS | The Leukemia & Lymphoma Society kicks off philanthropic campaign Light The Night; communities nationwide encouraged to learn why awareness and support is critical
RYE BROOK, N.Y., Sept. 3, 2024 /PRNewswire/ -- The Leukemia & Lymphom... |
| 03.09.2024 | Pharmaceutical Market: Trends, Segmentation, and Growth Opportunities | Share
Tweet
Share
Share
Email
In recent years, the pharmaceutical market has witnessed remarkable growth and transformation, driven by technological advancements, evolving consumer needs, and the global push for better healthcare solutions.... |
| 03.09.2024 | General Anesthesia Drugs Market: Trends, Segmentation, and Future Outlook | Share
Tweet
Share
Share
Email
The global general anesthesia drugs market has been experiencing significant evolution, driven by advancements in medical technology, increasing surgical procedures, and a growing emphasis on patient safety and... |
| 02.09.2024 | Документальный фильм о фреймворке, который изменил мир AI | Дэвид Касселл, автор статей для таких изданий, как CNN, MSNBC и Wall Street Journal Interactive Edition, рассказывает о PyTorch, фреймворке глубокого обучения, который используют более 60% AI-специалистов, через призму сюжета документальног... |
| 30.08.2024 | Gothenburg and AstraZeneca deepen ties to strengthen life science sector | Gothenburg and AstraZeneca deepen ties to strengthen life science sector
Fri, Aug 30, 2024 10:46 CET Report this content Read original
Gothenburg is to get its first regional business strategy for life science. The initiative comes from Bus... |
| 29.08.2024 | Navigating the New Normal: COVID Vaccines and Creative Leadership in Healthcare | The landscape of healthcare marketing is shifting. Imre, a prominent brand engagement agency, has made significant strides by appointing Tracy Zuto and Malia Baker as key creative leaders. Their arrival signals a commitment to innovative, i... |
| 29.08.2024 | Harbour BioMed and Keymed Biosciences: Navigating the Biopharmaceutical Landscape in 2024 | In the ever-evolving world of biopharmaceuticals, two companies stand out: Harbour BioMed and Keymed Biosciences. Both are charting ambitious paths through the complex terrain of drug development, showcasing resilience and innovation. Their... |
| 29.08.2024 | Great Place To Work Announces the Best Workplaces in Asia™ 2024 Representing 6.9 Million Employee Experiences | HANOI, Vietnam, Aug. 29, 2024 /PRNewswire/ -- Today, Great Place To Work® announced its Best Workplaces in Asia™ for 2024. The list is based on confidential survey data, with over 2.7 million individual responses representing the experience... |
| 29.08.2024 | The Fifth Qingdao Multinationals Summit kicked off | QINGDAO, China, Aug. 29, 2024 /PRNewswire/ -- On the morning of August 28, the Fifth Qingdao Multinationals Summit, jointly organized by the Ministry of Commerce of China and the People's Government of Shandong Province, opened at the Qingd... |
| 28.08.2024 | Imre announced two new appointments to Strengthen Brand AOR Expertise | Imre continues its commitment to cutting-edge creative that builds brand engagement with the appointment of two senior creative leaders, as the agency strengthens its position as a distinct choice for agency-of-record assignments in healthc... |
| 28.08.2024 | Inhalation Sciences AB (publ) releases Q2 Report 2024 | Inhalation Sciences AB (publ) releases Q2 Report 2024
Wed, Aug 28, 2024 08:30 CET Report this content
(Stockholm, Sweden, 28 August 2024) Inhalation Sciences AB announces that its Q2 Report for 2024 is now available on the company’s website... |
| 28.08.2024 | Harbour BioMed Announces 2024 Interim Results | CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Aug. 28, 2024 /PRNewswire/ -- Harbour BioMed ("HBM", or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development,... |
| 28.08.2024 | Harbour BioMed Announces 2024 Interim Results | CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Aug. 28, 2024 /PRNewswire/ -- Harbour BioMed ("HBM", or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development,... |
| 27.08.2024 | Imre Appoints Powerhouse Leaders Tracy Zuto and Malia Baker and Strengthens Brand AOR Expertise | New Additions Reflect Commitment to Creative Excellence and Healthcare Industry Leadership
NEW YORK, Aug. 27, 2024 /PRNewswire/ -- Imre continues its commitment to cutting-edge creative that builds brand engagement with the appointment of t... |
| 27.08.2024 | Keymed Biosciences Announces Interim Results for First Half of 2024 | CHENGDU, China , Aug. 27, 2024 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) today announced its interim results for the first half of 2024, along with a corporate update.
Rapid development of our pipeline products
Stapokibart (CM31... |
| 23.08.2024 | Qure.ai Receives FDA Clearance for AI-Powered Lung Nodule Analysis Tool | What You Should Know:
– Qure.ai, a global innovator in medical imaging AI, has today announced a pivotal 510(k) FDA clearance for its AI-powered chest CT solution – qCT LN Quant.
– The new AI solution is now available to support radiologist... |
| 21.08.2024 | Shifting Gears in Biotech: SciBase and AAX Biotech Make Strategic Moves | In the fast-paced world of biotechnology, change is the only constant. Companies must adapt, evolve, and sometimes pivot to stay relevant. Recently, two Swedish biotech firms, SciBase and AAX Biotech, made significant announcements that ref... |
| 21.08.2024 | AAX Biotech appoints Patrik Strömberg to Board of Directors, enhancing leadership team | AAX Biotech appoints Patrik Strömberg to Board of Directors, enhancing leadership team
Wed, Aug 21, 2024 07:30 CET Report this content
AAX Biotech is pleased to welcome Patrik Strömberg as new board member. Patrik Strömberg brings over two ... |
| 16.08.2024 | A New Dawn in Cancer Research: AI and Funding Unite for Hope | In the battle against cancer, innovation is the sword and funding is the shield. Two recent developments highlight this truth: a groundbreaking collaboration between Absci Corporation and Memorial Sloan Kettering Cancer Center (MSK), and a ... |
| 16.08.2024 | Imfinzi approved in US for resectable lung cancer | Imfinzi approved in US for resectable lung cancer
Fri, Aug 16, 2024 08:00 CET Report this content
16 August 2024
Imfinzi approved in the US for the treatment of resectable
non-small cell lung cancer before and after surgery
Based on AEGEAN ... |
| 15.08.2024 | Health | US drug price measure to cut costs by $7.5 billion in 2026 | Astra said it will accept the price reductions so patients can get its drugs. AbbVie said in a statement that the IRA does nothing to benefit patients and will harm the long-term development of new drugs. Merck and Amgen didn’t immediately ... |
| 14.08.2024 | The Digital Health Revolution: Merging Data and Care | The healthcare landscape is shifting. Digital health is no longer a side note; it’s the main act. Companies like Health Catalyst and AstraZeneca are leading the charge, reshaping how care is delivered and experienced. This transformation is... |
| 13.08.2024 | Registrational Phase III Study of Lisaftoclax in Newly-Diagnosed Patients with Higher-Risk Myelodysplastic Syndrome Cleared by China CDE | ROCKVILLE, Md. and SUZHOU, China, Aug. 13, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global, integrated biopharmaceutical company engaged in discovering, developing and commercializing both first- and best-in-class therapies for ma... |
| 13.08.2024 | The state of digital health investment, part 3: AstraZeneca | Photo courtesy of AstraZeneca
Pharma companies are seeing the value of digital health, and are creating departments focused on developing, scaling and investing in platforms that use technology to enhance life sciences R&D, better assis... |
| 12.08.2024 | Absci and MSK Collaborate on Generative AI Drug Discovery | What You Should Know:
– Absci Corporation, a leader in generative AI drug creation, today announced a strategic collaboration with Memorial Sloan Kettering Cancer Center (MSK) to develop up to six novel cancer therapeutics.
– By combining A... |
| 12.08.2024 | Forthcoming changes in Inhalation Sciences’ Board of Directors | Forthcoming changes in Inhalation Sciences’ Board of Directors
Mon, Aug 12, 2024 12:56 CET Report this content
Inhalation Sciences Sweden AB’s (publ) (“Inhalation Sciences” or the “Company”) Nomination Committee proposes that Ulf Ericsson b... |
| 11.08.2024 | Pinetree Therapeutics: $17 Million (Series A) Raised To Advance Protein Degradation Platform | Pinetree Therapeutics, a biotechnology company developing next-generation targeted protein degraders (TPD) to combat drug resistance in oncology and beyond, announced the completion of a Series A funding round, raising $17 million from new ... |
